SIGA Technologies

Yahoo Finance • 11 months ago

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

SIGA Technologies Inc. NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., wi... Full story

Yahoo Finance • last year

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023

- In Third Quarter, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - In October, Joint Procurement Framework Contract was signed by European Commission with Anticipated Ini... Full story

Yahoo Finance • last year

SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at... Full story

Yahoo Finance • last year

SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating Countries

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the creation by the European Commission’s DG HERA... Full story

Yahoo Finance • last year

SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executi... Full story

Yahoo Finance • last year

SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that SIGA CEO Phil Gomez, PhD, will present an ov... Full story

Yahoo Finance • 2 years ago

SIGA Declares Special Cash Dividend of $0.45 Per Share

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special cash dividend of $0.45 per share on the c... Full story

Yahoo Finance • 2 years ago

SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update a... Full story

Yahoo Finance • 2 years ago

Q4 2022 SIGA Technologies Inc Earnings Call

Participants Daniel J. Luckshire; Executive VP, CFO & Secretary; SIGA Technologies, Inc. Phillip Louis Gomez; CEO & Director; SIGA Technologies, Inc. Soo Romanoff; Analyst; Edison Investment Research Limited Presentation Operator Lad... Full story

Yahoo Finance • 2 years ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022

- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stag... Full story

Yahoo Finance • 2 years ago

13 High Growth Pharma Stocks that are Profitable

In this piece, we will take a look at 13 high growth pharma stocks that are profitable. For more stocks, head on over to 5 High Growth Pharma Stocks that are Profitable. One industry that has rapidly evolved with time and impacted million... Full story

Yahoo Finance • 2 years ago

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022

- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-s... Full story

Yahoo Finance • 2 years ago

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

Trials are currently underway in the United States, United Kingdom and Democratic Republic of Congo Pending positive results from clinical trials, SIGA plans to file with U.S. regulators for regulatory review of a TPOXX expanded indication... Full story

Yahoo Finance • 2 years ago

Is the Bubble Bursting for SIGA Technologies?

SIGA Technologies (NASDAQ: SIGA) has been one of the hottest stocks on the markets this year. Its monkeypox treatment Tpoxx has led to a spike in revenue, and investors have been optimistic it could generate even better numbers in the futu... Full story

Yahoo Finance • 2 years ago

Could SIGA Technologies Become the Next Moderna?

At the start of 2020, Moderna had a market capitalization of around $6.5 billion. One company that investors may be hoping to follow in its footsteps is SIGA Technologies (NASDAQ: SIGA). Earlier this month, the U.S. government declared the... Full story

Yahoo Finance • 2 years ago

U.S. buys $26 million of Siga's intravenous treatment for monkeypox

Siga Technologies Inc. said Tuesday that the U.S. government is exercising the option to acquire $26 million of the company's intravenous monkeypox treatment and fund a post-marketing study for the therapy. Siga said it plans to deliver th... Full story

Yahoo Finance • 2 years ago

SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®

- IV TPOXX is an Important Option for Those Unable to Swallow – - Option to Fund Post-Marketing Field Study for IV TPOXX also Exercised – NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a com... Full story

Yahoo Finance • 2 years ago

SIGA Will Seek FDA Approval of Monkeypox Treatment When Data Is Available, CEO Says

The monkeypox outbreak has sent the drugmaker's stock up more than 200% this year, though the company’s monkeypox antiviral remains hard to access in the U.S.... Full story

Yahoo Finance • 2 years ago

NanoViricides shares soar 41% after announcing plans to develop a monkeypox treatment

Shares of NanoViricides Inc. jumped 41.8% in premarket trading on Thursday after the company said it began developing a monkeypox treatment. There are currently no approved or authorized therapies for monkeypox, though the Food and Drug Ad... Full story

Yahoo Finance • 2 years ago

SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at... Full story